Moolec Science (MLECW) Capital Expenditures (2023 - 2024)
Moolec Science (MLECW) posted Capital Expenditures of -$4.1 million for Q4 2024, down 6734.62% sequentially from -$59738.0 in Q3 2024, and up 33.36% YoY from -$3.1 million in Q1 2024.
Moolec Science (MLECW) Capital Expenditures (2023 - 2024) Analysis & Trends
Moolec Science has reported Capital Expenditures for 2 years, with the latest figure at -$4.1 million in Q4 2024.
- Quarterly Capital Expenditures rose 33.36% year-over-year to -$4.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $5.9 million (changed N/A YoY) and the FY2025 annual result came in at $5.7 million, down 43.12% from the prior year.
- Capital Expenditures eased to -$4.1 million in Q4 2024 per MLECW's latest filing, from -$59738.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $11.5 million in Q2 2023 and troughed at -$6.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -4.08 Mn |
| Dec 31, 2024 | -4.08 Mn |
| Sep 30, 2024 | -59,738.00 |
| Sep 30, 2024 | -59,738.00 |
| Jun 30, 2024 | 10.06 Mn |
| Jun 30, 2024 | 10.06 Mn |
| Mar 31, 2024 | -30,326.00 |
| Mar 31, 2024 | -30,326.00 |
| Dec 31, 2023 | -6.13 Mn |
| Dec 31, 2023 | -6.13 Mn |
| Sep 30, 2023 | -104,441.00 |
| Sep 30, 2023 | -104,441.00 |
| Jun 30, 2023 | 11.49 Mn |
| Jun 30, 2023 | 11.49 Mn |